[go: up one dir, main page]

HK40034991A - Cd137 antibodies and tumor antigen-targeting antibodies and uses thereof - Google Patents

Cd137 antibodies and tumor antigen-targeting antibodies and uses thereof Download PDF

Info

Publication number
HK40034991A
HK40034991A HK62021024360.1A HK62021024360A HK40034991A HK 40034991 A HK40034991 A HK 40034991A HK 62021024360 A HK62021024360 A HK 62021024360A HK 40034991 A HK40034991 A HK 40034991A
Authority
HK
Hong Kong
Prior art keywords
antibodies
tumor antigen
targeting
targeting antibodies
antigen
Prior art date
Application number
HK62021024360.1A
Other languages
Chinese (zh)
Inventor
Robert V. TIGHE, III
Ugur ESKIOCAK
Original Assignee
Compass Therapeutics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Compass Therapeutics Llc filed Critical Compass Therapeutics Llc
Publication of HK40034991A publication Critical patent/HK40034991A/en

Links

HK62021024360.1A 2017-11-20 2018-11-20 Cd137 antibodies and tumor antigen-targeting antibodies and uses thereof HK40034991A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62/588,764 2017-11-20
US62/754,764 2018-11-02

Publications (1)

Publication Number Publication Date
HK40034991A true HK40034991A (en) 2021-05-07

Family

ID=

Similar Documents

Publication Publication Date Title
EP3625263B8 (en) Anti-galectin-9 antibodies and uses thereof
EP3596119A4 (en) Anti-phf-tau antibodies and uses thereof
EP3589313A4 (en) Anti-tigit antibodies
EP3606961B8 (en) Garp-tgf-beta antibodies
EP3270965A4 (en) Cd48 antibodies and conjugates thereof
EP3658185A4 (en) Anti-tim-3 antibodies and uses thereof
EP3675898A4 (en) Anti-lag-3 antibodies and uses thereof
EP3720491A4 (en) Anti-cd137 antibodies and uses thereof
EP3774888A4 (en) Anti-phf-tau antibodies and uses thereof
EP3529273A4 (en) Anti-o1 antibodies and uses thereof
EP3894439A4 (en) Anti-periostin antibodies and uses thereof
EP3681541A4 (en) Melanin antibodies and uses thereof
EP3724657A4 (en) Anti-cannabidiol antibody and uses thereof
HK40034991A (en) Cd137 antibodies and tumor antigen-targeting antibodies and uses thereof
HK40035592A (en) Modified anti-sirpa antibodies and uses thereof
HK40027176A (en) Anti-galectin-9 antibodies and uses thereof
HK40034341A (en) Axl-specific antibodies and uses thereof
HK40031036A (en) Anti-cd166 antibodies and uses thereof
HK40030314A (en) Anti-fam19a5 antibodies and uses thereof
HK40019216A (en) Anti-phf-tau antibodies and uses thereof
HK40022718A (en) Anti-par2 antibodies and uses thereof
HK40062337A (en) Anti-alpha-synuclein antibodies and uses thereof
HK40050823A (en) Anti-nkg2a antibodies and uses thereof
HK40052682A (en) Anti-il-27 antibodies and uses thereof
HK40052560A (en) Anti-cxcr2 antibodies and uses thereof